LAGEPP

What LAGEPP does

LAGEPP (Laboratoire d'Automatique, de Génie des Procédés et de Génie Pharmaceutique) is a French public research laboratory founded in 1988, headquartered on the Campus de la Doua in Villeurbanne (Auvergne-Rhône-Alpes, France), operating under the dual supervision of Université Claude Bernard Lyon 1 (UCBL) and the CNRS. The laboratory is organized into three research teams: DYCOP (Dynamics, Control and Observation of Processes), GEPHARM (Pharmaceutical Engineering), and PRODIS (Dispersed Media Processes). It supports doctoral training and applied research in automatic control, polymerization engineering, pharmaceutical formulation and dispersed-media processing, and is directed by Stéphanie Briançon with a team of 48 personnel.

Its technology base centers on domain-specialized process engineering and pharmaceutical technology rather than commercial software products. Core capabilities include nonlinear automatic control methodologies (e.g., nonlinear integral action and PID regulators for nonlinear systems applied to heat exchangers), advanced process analytics (including additive analysis for process monitoring and characterization of polypropylene solvent-based recycling), and a portfolio of research platforms (CosLife, Innobiovir, DADY) plus scientific equipment services spanning physico-chemical analyses, thermal analyses, bioproduction, imaging, separative analyses, spectroscopy, cell culture and galenic formulation. Notable capability assets include recognition of Hatem Fessi as a Clarivate Highly Cited Researcher (2022) and a Process Analytics Award at EuroPACT-2026 for Sofiane Ferchichi.

LAGEPP does not operate a commercial revenue model. It is funded through public research grants from ANR (Agence Nationale de la Recherche), CNRS, and UCBL, with technology-transfer activity channeled via the Institut Carnot network and joint laboratories such as LabCom LIFOD with Skyepharma (inaugurated 2026-07-02 under ANR LabCom 2025). GTM is academic: scientific conferences, society webinars (e.g., SFGP), open-archive publication (HAL), and institutional partnerships with CPE Lyon, Institut de Chimie de Lyon, SFGP, GFP, H2O Lyon and LYSE. The lab serves academic researchers, doctoral students, and selected industrial partners in pharmaceutical formulation and polymerization processes, with no commercial pricing or disclosed revenue figures.

Name

LAGEPP

Legal name

Laboratoire d'Automatique, de Génie des Procédés et de Génie Pharmaceutique

Website

https://lagepp.univ-lyon1.fr

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

LAGEPP is a French public research laboratory under Université Claude Bernard Lyon 1 and CNRS, organized into DYCOP, GEPHARM and PRODIS teams, conducting research in process control, pharmaceutical engineering and polymerization, funded via public grants and ANR LabCom joint laboratories with industry.

Ownership category

akta.pro rank

Headquarters

HQ city

Villeurbanne

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Infrastructure, Technology or R&D, Operations, Others

Revenue model

1. Public Research Funding: Government and institutional funding from ANR (Agence nationale de la recherche), CNRS, and Université Claude Bernard Lyon 1

Distribution channels1 record

Marketing channels4 records

Core offering

LAGEPP is a French public research laboratory that conducts academic and applied research in automatic control, process engineering, and pharmaceutical technology through three teams (DYCOP, GEPHARM, PRODIS). It provides access to scientific platforms (CosLife, Innobiovir, DADY) and specialized equipment services for physico-chemical analyses, thermal analyses, bioproduction, imaging, separative analyses, spectroscopy, cell culture, and galenic formulation. It does not sell commercial software products, instead delivering research expertise, equipment access, and collaborative research services funded primarily by public grants and joint labs.

Product overview

LAGEPP (Laboratoire d'Automatique, de Génie des Procédés et de Génie Pharmaceutique) is a research laboratory affiliated with Université Claude Bernard Lyon 1 and CNRS. The laboratory operates as a unified research institution organized into three main teams: DYCOP (Dynamics, Control and Observation of Processes), GEPHARM (Pharmaceutical Engineering), and PRODIS (Dispersed Media Processes). It provides access to scientific research platforms including CosLife, Innobiovir, and DADY, as well as specialized equipment services for physico-chemical analyses, thermal analyses, bioproduction, imaging, separative analyses, spectroscopy, cell culture, and galenic formulation. The laboratory does not offer commercial software products but rather research expertise, equipment access, and collaborative research services.

Differentiator

Problem solved

Functional benefit

Brands

• DYCOP: Dynamique, Commande et Observation des Procédés (Dynamics, Control and Observation of Processes) - one of the three research teams at LAGEPP
• GEPHARM
• PRODIS

Products and services

• Physico-chemical Analyses and Controls Laboratory service providing physico-chemical analysis and quality control capabilities for research projects.
• Thermal Analyses Thermal analysis equipment and services for material characterization.
• Bioproduction Bioproduction equipment and capabilities for biological product development.
• Imaging Imaging equipment and analysis services for research applications.
• Separative Analyses Chromatography and separative analysis techniques and equipment.
• Spectroscopy Spectroscopic analysis equipment and services.
• Cell Culture Cell culture facilities and services for biological research.
• Galenic Formulation Equipment Equipment for pharmaceutical formulation and galenic drug development.
• CosLife Platform Scientific research platform focused on cosmetic and life sciences research, offering equipment and expertise.
• Innobiovir Platform Alliance of research equipment and expertise providing a comprehensive research offer in biotechnology and bioproduct development.
• DADY Platform Research platform for analysis and development activities at LAGEPP.
• LabCom LIFOD Joint Laboratory Joint laboratory (Lab of Innovative Formulation for Oral Delivery) between LAGEPP and Skyepharma, supported by ANR LabCom 2025, developing innovative solutions for oral drug formulation and administration.

Quantifiable outcome

• LabCom LIFOD inaugurated 2026 to develop innovative solutions for oral drug formulation

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Ten partnerships are on record, tiered major, core and minor.

• SFGP (Société Française de Génie des Procédés)majorStrategic or Co-development Partner · 24 September 2026French Society of Process Engineering partnership for webinars and knowledge sharing on automatic control for process engineering
• SkyepharmacoreStrategic or Co-development Partner · 2 July 2026LabCom LIFOD (Lab of Innovative Formulation for Oral Delivery) partnership focused on developing innovative solutions for pharmaceutical formulation and oral drug administration, combining academic research with industrial expertise
• GFP (Groupe Français de Polymérisation)majorStrategic or Co-development Partner · 18 November 2025French Polymer Group collaboration for polymerization reactor scientific day bringing together industrial and academic experts
• Université Claude Bernard Lyon 1coreStrategic or Co-development PartnerPrimary institutional partner and host university for LAGEPP research laboratory
• CNRScoreStrategic or Co-development PartnerCo-supervising research institution providing institutional support and national research framework
• CPE LyonmajorStrategic or Co-development PartnerEngineering school partner hosting LAGEPP facilities and collaborating on process engineering research
• Institut CarnotmajorStrategic or Co-development PartnerCarnot network partnership for technology transfer and applied research
• Institut de Chimie de Lyon (ICL)majorStrategic or Co-development PartnerChemistry institute alliance within Lyon research ecosystem
• H2O LyonminorOthersWater and environment research cluster partnership in Lyon ecosystem
• LYSEminorOthersLyon Solar Energy research cluster partnership

Scale indicators3 records

Recent moves7 records

Expansion highlights4 records

Direct peers

• RAPSODEE (IMT Mines Albi): Research center at IMT Mines Albi focused on process engineering for powders, polymers, and dispersed media. Comparable to LAGEPP in its blend of industrial process R&D and academic mission.
• LRGP (Laboratoire Réactions et Génie des Procédés): CNRS-affiliated French process engineering laboratory at Université de Lorraine. Closely comparable to LAGEPP's DYCOP and PRODIS teams in process control, reaction engineering, and dispersed media research.
• Institut Galien Paris-Saclay: CNRS/University Paris-Saclay pharmaceutical science unit focused on drug formulation, delivery, and pharmaceutical engineering — directly comparable to LAGEPP's GEPHARM team.
• IFP Energies nouvelles (IFPEN): French public R&D institution conducting applied research in process engineering, polymers, and sustainable materials. Comparable to LAGEPP in bridging academic R&D with industrial technology transfer.
• LGC (Laboratoire de Génie Chimique, Toulouse): CNRS/INPT/UPS joint laboratory covering process engineering, reactive systems, and bioprocesses. Comparable to LAGEPP's combined process-engineering and pharmaceutical-technology scope.

Others

• INSA Lyon: Local Lyon engineering school with adjacent process engineering and bioscience research groups. Ecosystem partner sharing doctoral students, platforms, and grants with LAGEPP.

Emerging players

• Gattefossé: French specialty excipient and pharmaceutical formulation company with active R&D programs overlapping LAGEPP's GEPHARM focus on formulation and process development.

Regional players

• Max Planck Institute for Polymer Research: German research institute with deep polymer and polymerization research. Comparable to LAGEPP's DYCOP polymerization and process analytics work, but operating in a different geography.
• ETH Zurich — Department of Mechanical and Process Engineering: European university research department in process engineering and control. Comparable to LAGEPP's DYCOP team in process automation and control methodology, but operating in a different geography.

Broad incumbents

• Sanofi: Global French-headquartered pharmaceutical company with extensive formulation and process R&D capabilities. A natural large-scale industrial counterpart to LAGEPP's pharmaceutical engineering expertise.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/lagepp

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LAGEPP